{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:01:20Z","timestamp":1790395280461,"version":"4.1.0"},"reference-count":27,"publisher":"Pharmaceutical Society of Japan","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2026,9,26]]},"DOI":"10.1248\/bpb.b26-00304","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:12:39Z","timestamp":1790374359000},"page":"1561-1569","source":"Crossref","is-referenced-by-count":0,"title":["Sex Differences in Sentiment-Scored Vocabulary Patterns in VAERS Free-Text Narratives of Four Major Vaccine Categories"],"prefix":"10.1248","volume":"49","author":[{"given":"Kae","family":"Matsumura","sequence":"first","affiliation":[{"name":"Laboratory of Drug Informatics, Gifu Pharmaceutical University, 1\u201325\u20134 Daigaku-Nishi, Gifu 501\u20131196, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Horibe","sequence":"additional","affiliation":[{"name":"Department of Nursing, School of Health Sciences, Asahi University, Gifu 501\u20130296, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Ino","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmaceutical Health Care and Promotion, Gifu Pharmaceutical University, 1\u201325\u20134 Daigaku-Nishi, Gifu 501\u20131196, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kana","family":"Sugishita","sequence":"additional","affiliation":[{"name":"Laboratory of Drug Informatics, Gifu Pharmaceutical University, 1\u201325\u20134 Daigaku-Nishi, Gifu 501\u20131196, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomofumi","family":"Yamazaki","sequence":"additional","affiliation":[{"name":"Laboratory of Drug Informatics, Gifu Pharmaceutical University, 1\u201325\u20134 Daigaku-Nishi, Gifu 501\u20131196, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moe","family":"Maeno","sequence":"additional","affiliation":[{"name":"Laboratory of Drug Informatics, Gifu Pharmaceutical University, 1\u201325\u20134 Daigaku-Nishi, Gifu 501\u20131196, Japan"},{"name":"Department of Pharmacy, University of Miyazaki Hospital, 5200 Kihara, Kiyotake-cho, Miyazaki 889\u20131692, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Kageyama","sequence":"additional","affiliation":[{"name":"Laboratory of Drug Informatics, Gifu Pharmaceutical University, 1\u201325\u20134 Daigaku-Nishi, Gifu 501\u20131196, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiichiro","family":"Ito","sequence":"additional","affiliation":[{"name":"Laboratory of Drug Informatics, Gifu Pharmaceutical University, 1\u201325\u20134 Daigaku-Nishi, Gifu 501\u20131196, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mugita","family":"Sato","sequence":"additional","affiliation":[{"name":"Laboratory of Drug Informatics, Gifu Pharmaceutical University, 1\u201325\u20134 Daigaku-Nishi, Gifu 501\u20131196, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahiro","family":"Chikahisa","sequence":"additional","affiliation":[{"name":"Laboratory of Drug Informatics, Gifu Pharmaceutical University, 1\u201325\u20134 Daigaku-Nishi, Gifu 501\u20131196, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayumi","family":"Kitamura","sequence":"additional","affiliation":[{"name":"Department of Nursing, School of Health Sciences, Asahi University, Gifu 501\u20130296, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Iwata","sequence":"additional","affiliation":[{"name":"Yanaizu Pharmacy, Gifu 501\u20136103, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Iguchi","sequence":"additional","affiliation":[{"name":"Laboratory of Community Pharmacy, Gifu Pharmaceutical University, 1\u201325\u20134 Daigaku-Nishi, Gifu 501\u20131196, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhiro","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Laboratory of Drug Informatics, Gifu Pharmaceutical University, 1\u201325\u20134 Daigaku-Nishi, Gifu 501\u20131196, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","unstructured":"1) Centers for Disease Control and Prevention. \u201cVaccines &amp; Immunizations.\u201d: \u2039https:\/\/www.cdc.gov\/vaccines\/index.html\u203a, accessed 13 May, 2026."},{"key":"2","unstructured":"2) Centers for Disease Control and Prevention. \u201cVaccines and the Diseases They Prevent.\u201d: \u2039https:\/\/www.cdc.gov\/vaccines\/by-disease\/index.html\u203a, accessed 13 May, 2026."},{"key":"3","unstructured":"3) World Health Organization. \u201cTen threats to global health in 2019.\u201d: \u2039https:\/\/www.who.int\/news-room\/spotlight\/ten-threats-to-global-health-in-2019\u203a, accessed 13 May, 2026."},{"key":"4","unstructured":"4) Centers for Disease Control and Prevention. \u201cAbout the Vaccine Adverse Event Reporting System (VAERS).\u201d: \u2039https:\/\/www.cdc.gov\/vaccine-safety-systems\/vaers\/index.html\u203a, accessed 13 May, 2026."},{"key":"5","unstructured":"5) U.S. Food and Drug Administration. \u201cVAERS Overview.\u201d: \u2039https:\/\/www.fda.gov\/vaccines-blood-biologics\/vaccine-adverse-events\/vaers-overview\u203a, accessed 13 May, 2026."},{"key":"6","unstructured":"6) Centers for Disease Control and Prevention. \u201cVaccine Adverse Event Reporting System (VAERS) Data Search.\u201d: \u2039https:\/\/wonder.cdc.gov\/vaers.html\u203a, accessed 13 May, 2026."},{"key":"7","unstructured":"7) Nielsen F\u00c5. A new ANEW: Evaluation of a word list for sentiment analysis in microblogs. <i>Proceedings of the ESWC2011 Workshop on Making Sense of Microposts: Big Things Come in Small Packages<\/i>, pp. 93\u201398 (2011)."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Mohammad SM, Turney PD. Crowdsourcing a word-emotion association lexicon. <i>Comput. Intell.<\/i>, <b>29<\/b>, 436\u2013465 (2013).","DOI":"10.1111\/j.1467-8640.2012.00460.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Azarpanah H, Farhadloo M, Vahidov R, Pilote L. Vaccine hesitancy: Evidence from an adverse events following immunization database, and the role of cognitive biases. <i>BMC Public Health<\/i>, <b>21<\/b>, 1686 (2021).","DOI":"10.1186\/s12889-021-11745-1"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Jun J, Zain A, Chen Y, Kim SH. Adverse mentions, negative sentiment, and emotions in COVID-19 vaccine tweets and their association with vaccination uptake: Global comparison of 192 countries. <i>Vaccines<\/i>, <b>10<\/b>, 735 (2022).","DOI":"10.3390\/vaccines10050735"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Xu J, Wu Z, Wass L, Larson HJ, Lin L. Mapping global public perspectives on mRNA vaccines and therapeutics. <i>NPJ Vaccines<\/i>, <b>9<\/b>, 218 (2024).","DOI":"10.1038\/s41541-024-01019-3"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Silge J, Robinson D. tidytext: Text mining and analysis using tidy data principles in R. <i>J. Open Source Softw.<\/i>, <b>1<\/b>, 37 (2016).","DOI":"10.21105\/joss.00037"},{"key":"13","unstructured":"13) Silge J, Robinson D. <i>Text Mining with R: A Tidy Approach<\/i>. O\u2019Reilly Media, Sebastopol (2017)."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Yin A, Wang N, Shea PJ, Rosser EN, Kuo H, Shapiro JR, Fenstermacher KZJ, Pekosz A, Rothman RE, Klein SL, Morgan R. Sex and gender differences in adverse events following influenza and COVID-19 vaccination. <i>Biol. Sex Differ.<\/i>, <b>15<\/b>, 50 (2024).","DOI":"10.1186\/s13293-024-00625-z"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Green MS, Peer V, Magid A, Hagani N, Anis E, Nitzan D. Gender differences in adverse events following the Pfizer-BioNTech COVID-19 vaccine. <i>Vaccines<\/i>, <b>10<\/b>, 233 (2022).","DOI":"10.3390\/vaccines10020233"},{"key":"16","unstructured":"16) Centers for Disease Control and Prevention. \u201cCOVID-19 Vaccine Safety.\u201d: \u2039https:\/\/www.cdc.gov\/vaccine-safety\/vaccines\/covid-19.html\u203a, accessed 13 May, 2026."},{"key":"17","unstructured":"17) Centers for Disease Control and Prevention. \u201cInfluenza (Flu) Vaccine Safety.\u201d: \u2039https:\/\/www.cdc.gov\/vaccine-safety\/vaccines\/flu.html\u203a, accessed 13 May, 2026."},{"key":"18","unstructured":"18) World Health Organization. \u201cSafety of HPV vaccines.\u201d: \u2039https:\/\/www.who.int\/groups\/global-advisory-committee-on-vaccine-safety\/topics\/human-papillomavirus-vaccines\/safety\u203a, accessed 13 May, 2026."},{"key":"19","unstructured":"19) Centers for Disease Control and Prevention. \u201cHPV Vaccination.\u201d: \u2039https:\/\/www.cdc.gov\/hpv\/vaccines\/index.html\u203a, accessed 13 May, 2026."},{"key":"20","unstructured":"20) Centers for Disease Control and Prevention. \u201cMeasles, Mumps, and Rubella (MMR) Vaccine Safety.\u201d: \u2039https:\/\/www.cdc.gov\/vaccine-safety\/vaccines\/mmr.html\u203a, accessed 13 May, 2026."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Shiota K, Horibe M, Ino Y, Iwata M, Tanaka H, Kitamura M, Iguchi K, Nakamura M. Text mining of symptom descriptions in the Vaccine Adverse Event Reporting System for human papillomavirus vaccination. <i>Cureus<\/i>, <b>17<\/b>, e92575 (2025).","DOI":"10.7759\/cureus.92575"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Slingerland P, van Hunsel FPAM, Lieber T, van Balveren L, Duijster JW. The effect of sex on the incidence, latency, duration and perceived burden of adverse events following seasonal influenza vaccination in the Netherlands. <i>Drug Saf.<\/i>, <b>46<\/b>, 1323\u20131334 (2023).","DOI":"10.1007\/s40264-023-01356-7"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Moor J, Toepfner N, von Mei\u00dfner WCG, Berner R, Moor MB, Kublickiene K, Strumann C, Chao CM. Sex differences in symptoms following the administration of BNT162b2 mRNA COVID-19 vaccine in children below 5 years of age in Germany (CoVacU5): a retrospective cohort study. <i>Biol. Sex Differ.<\/i>, <b>15<\/b>, 74 (2024).","DOI":"10.1186\/s13293-024-00651-x"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Sanglerdsinlapachai N, Plangprasopchok A, Ho TB, Nantajeewarawat E. Improving sentiment analysis on clinical narratives by exploiting UMLS semantic types. <i>Artif. Intell. Med.<\/i>, <b>113<\/b>, 102033 (2021).","DOI":"10.1016\/j.artmed.2021.102033"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Lu KJQ, Meaney C, Guo E, Leung FH. Evaluating the applicability of existing lexicon-based sentiment analysis techniques on family medicine resident feedback field notes: retrospective cohort study. <i>JMIR Med. Educ.<\/i>, <b>9<\/b>, e41953 (2023).","DOI":"10.2196\/41953"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Holderness E, Cawkwell P, Bolton K, Pustejovsky J, Hall MH. Distinguishing clinical sentiment: the importance of domain adaptation in psychiatric patient health records. <i>Proceedings of the 2nd Clinical Natural Language Processing Workshop<\/i>. pp. 117\u2013123 (2019).","DOI":"10.18653\/v1\/W19-1915"},{"key":"27","unstructured":"27) Zhou W, Pool V, Iskander JK, English-Bullard R, Ball R, Wise RP, Haber P, Pless RP, Mootrey G, Ellenberg SS, Braun MM, Chen RT. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)\u2014United States, 1991\u20132001. <i>MMWR Surveill. Summ.<\/i>, <b>52<\/b>, 1\u201324 (2003)."}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/9\/49_b26-00304\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:29:01Z","timestamp":1790393341000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/9\/49_b26-00304\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,26]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b26-00304","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,26]]},"article-number":"b26-00304"}}